Comparing Guided Therapeutics (OTCMKTS:GTHP) & Precision Optics (NASDAQ:POCI)

Valuation & Earnings

This table compares Precision Optics and Guided Therapeutics”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precision Optics	$17.63 million	2.06	-$2.95 million	($0.89)	-5.33
Guided Therapeutics	$100,000.00	131.46	-$3.49 million	($0.05)	-3.33

Precision Optics has higher revenue and earnings than Guided Therapeutics. Precision Optics is trading at a lower price-to-earnings ratio than Guided Therapeutics, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

13.7% of Precision Optics shares are held by institutional investors. Comparatively, 9.7% of Guided Therapeutics shares are held by institutional investors. 13.0% of Precision Optics shares are held by company insiders. Comparatively, 66.8% of Guided Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

Precision Optics has a beta of 0.21, meaning that its share price is 79% less volatile than the S&P 500. Comparatively, Guided Therapeutics has a beta of 0.21, meaning that its share price is 79% less volatile than the S&P 500.

Profitability

This table compares Precision Optics and Guided Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Precision Optics	-21.46%	-39.17%	-22.93%
Guided Therapeutics	N/A	N/A	-151.93%

Summary

Guided Therapeutics beats Precision Optics on 6 of the 10 factors compared between the two stocks.

About Precision Optics

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

About Guided Therapeutics

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.